Bioinvent International Ab
Clinical trials sponsored by Bioinvent International Ab, explained in plain language.
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called BI-1808, alone or with another drug (pembrolizumab), in people with advanced cancers (like ovarian cancer, melanoma, or T-cell lymphoma) that have not responded to standard treatments. The main goals are to check safety, find the bes…
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New hope for hard-to-treat cancers? drug combo enters human testing
Disease control Recruiting nowThis early-stage trial tests a new antibody (BI-1206) combined with an existing immunotherapy (pembrolizumab) in adults with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and can help control the disease. …
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 12, 2026 13:41 UTC